Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Transient Elevation of Plasma Glucocorticoids Supports Psilocybin-Induced Anxiolysis in Mice
N. Jones, Zarmeen Zahid, Sean M. Grady, et al.
ACS Pharmacology & Translational Science (2023) Vol. 6, Iss. 8, pp. 1221-1231
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Psilocybin-enhanced fear extinction linked to bidirectional modulation of cortical ensembles
Sophie A. Rogers, Elizabeth A. Heller, Gregory Corder
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 7
In vivo validation of psilacetin as a prodrug yielding modestly lower peripheral psilocin exposure than psilocybin
N. Jones, Laura M. Wagner, Molly C. Pellitteri Hahn, et al.
Frontiers in Psychiatry (2024) Vol. 14
Open Access | Times Cited: 7
High-resolution tracking of unconfined zebrafish behavior reveals stimulatory and anxiolytic effects of psilocybin
Dotan Braun, Ayelet M Rosenberg, Elad Rabaniam, et al.
Molecular Psychiatry (2024) Vol. 29, Iss. 4, pp. 1046-1062
Open Access | Times Cited: 6
Effects of psilocybin, psychedelic mushroom extract and 5-hydroxytryptophan on brain immediate early gene expression: Interaction with serotonergic receptor modulators
Elad Lerer, Alexander Botvinnik, Orr Shahar, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 6
Psilocybin for the treatment of Alzheimer’s disease
Siyi Zheng, Rong Ma, Yang Yang, et al.
Frontiers in Neuroscience (2024) Vol. 18
Open Access | Times Cited: 6
Psilocybin induces acute anxiety and changes in amygdalar phosphopeptides independently from the 5-HT2A receptor
Ram Harari, Ipsita Chatterjee, Dmitriy Getselter, et al.
iScience (2024) Vol. 27, Iss. 5, pp. 109686-109686
Open Access | Times Cited: 5
Neurobiological mechanisms of antidepressant properties of psilocybin: A systematic review of blood biomarkers
Juliana Lima Constantino, Jens H. van Dalfsen, Sara Massetti, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025) Vol. 136, pp. 111251-111251
Open Access
Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases
Zarah R. Haniff, Mariia Bocharova, Tim Mantingh, et al.
Pharmacology & Therapeutics (2024) Vol. 258, pp. 108641-108641
Open Access | Times Cited: 4
Early psilocybin intervention alleviates behavioral despair and cognitive impairment in stressed Wistar rats
Zitong Wang, Brett Robbins, R. L. Zhuang, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111243-111243
Open Access
Psychedelic Drugs in Mental Disorders: Current Clinical Scope and Deep Learning‐Based Advanced Perspectives
Sung‐Hyun Kim, Sumin Yang, Jeehye Jung, et al.
Advanced Science (2025)
Open Access
The effect of low-dose psilocybin on brain neurotransmission and rat behavior
Agnieszka Bysiek, Adam Wojtas, Izabela Szpręgiel, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2025), pp. 111347-111347
Closed Access
Psilocybin and Eugenol Reduce Inflammation in Human 3D EpiIntestinal Tissue
Gregory Ian Robinson, Dongping Li, Bo Wang, et al.
Life (2023) Vol. 13, Iss. 12, pp. 2345-2345
Open Access | Times Cited: 9
Psilocybin and eugenol prevent DSS-induced neuroinflammation in mice
Timur Zanikov, Marta Gerasymchuk, Gregory Ian Robinson, et al.
Biocatalysis and Agricultural Biotechnology (2024) Vol. 56, pp. 103033-103033
Closed Access | Times Cited: 3
Novel extended-release transdermal formulations of the psychedelic N,N-dimethyltryptamine (DMT)
Christopher G. Witowski, M. Hess, N. Jones, et al.
European Journal of Pharmaceutical Sciences (2024) Vol. 199, pp. 106803-106803
Open Access | Times Cited: 3
Psilocybin as a lead candidate molecule in preclinical therapeutic studies of psychiatric disorders: A systematic review
James J Gattuso, Carey Wilson, Anthony J. Hannan, et al.
Journal of Neurochemistry (2023)
Open Access | Times Cited: 7
Co-administration of midazolam and psilocybin: differential effects on subjective quality versus memory of the psychedelic experience
Christopher R. Nicholas, Matthew I. Banks, Richard Lennertz, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Psilocybin reduces heroin seeking behavior and modulates inflammatory gene expression in the nucleus accumbens and prefrontal cortex of male rats
Gabriele Floris, Konrad Dabrowski, Mary Tresa Zanda, et al.
Molecular Psychiatry (2024)
Open Access | Times Cited: 2
Concurrent stress modulates the acute and post-acute effects of psilocybin in a sex-dependent manner.
Miguel Farinha‐Ferreira, Catarina Miranda‐Lourenço, Chloé Galipeau, et al.
Neuropharmacology (2024) Vol. 266, pp. 110280-110280
Closed Access | Times Cited: 2
Single administration of a psychedelic [(R)-DOI] influences coping strategies to an escapable social stress
Kevin T. Krupp, Jazmine D. W. Yaeger, Leighton J. Ledesma, et al.
Neuropharmacology (2024) Vol. 252, pp. 109949-109949
Open Access | Times Cited: 1
Psilocybin decreases neural responsiveness and increases functional connectivity while preserving pure-tone frequency selectivity in mouse auditory cortex
Adam T. Brockett, Nikolas A. Francis
Journal of Neurophysiology (2024) Vol. 132, Iss. 1, pp. 45-53
Open Access | Times Cited: 1
Co-administration of midazolam and psilocybin: Differential effects on subjective quality versus memory of the psychedelic experience
Christopher R. Nicholas, Matthew I. Banks, Richard Lennertz, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Evaluating the potential for psilocybin as a treatment for post-traumatic stress disorder
Claire Miller, Phillip R. Zoladz
Journal of Pharmacology and Experimental Therapeutics (2024) Vol. 392, Iss. 1, pp. 100026-100026
Closed Access | Times Cited: 1
Psychedelics: A review of their effects on recalled aversive memories and fear/anxiety expression in rodents
Isabel Werle, Leandro J. Bertoglio
Neuroscience & Biobehavioral Reviews (2024), pp. 105899-105899
Closed Access | Times Cited: 1
Psilocybin Reduces Grooming in the SAPAP3 Knockout Mouse Model of Compulsive Behaviour
James J Gattuso, Carey Wilson, Anthony J. Hannan, et al.
Neuropharmacology (2024) Vol. 262, pp. 110202-110202
Closed Access | Times Cited: 1
Identification of Different Extracts and Phytoconstituents of Callistemon Viminalis Cheel for Their Anti-Anxiety Effects Based on Pharmacognostic, Toxicological, and Pharmacological Strategies
N. Kumari, Arun Mittal, Arpana Rana, et al.
Toxicology Reports (2024) Vol. 13, pp. 101726-101726
Open Access
Page 1 - Next Page

Scroll to top